生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Spleen tyrosine kinase (Syk) is an intracellular cytoplasmic tyrosine kinase that mediates immunoreceptor signaling primarily in hematopoietic cells. GS-9973 is a potent, selective, and orally bioavailable Sky inhibitor with an EC50 value of 26 nM[1]. The level of phosphorylated Akt and ribosomal S6 in primary chronic lymphocytic leukemia (CLL) cells was decreased by 100 nM GS-9973 compared to control cells, while idelalisib and GS-9973 in combination (100 nM each) showed more potent inhibitory effect on Akt and ribosomal S6 phosphorylation. Compared to single agent treatment, the combination of GS-9973 (0.01 - 10 μM) and idelalisib (0.01 - 10 μM) synergistically decreased the cell viability of CLL cells isolated from the peripheral blood or bone marrow[2]. In a rat collagen-induced arthritis model, twice daily oral dosing with GS-9973 at 10, 3, and 1 mg/kg significantly inhibited ankle inflammation. Histological analyses showed that GS-9973 inhibited cartilage damage, bone resorption, pannus formation, and peritosteal bone formation with ED50 values ranging from 1.2 to 3.9 mg/kg[1]. | ||
作用机制 | GS-9973 is a selective, orally efficacious, imidazopyrazine-based inhibitor of Syk that forms a hydrogen bond with the D512 side chain of Syk kinase[1]. |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
C57BL/6 mouse bone marrow cells | Cytotoxic assay | 4 days | Cytotoxicity against C57BL/6 mouse bone marrow cells assessed as growth inhibition preincubated for 4 days followed by [3H]-thymidine addition measured after 5 hrs by betaplate counting analysis, IC50=0.582 μM | 25633741 | |
human MV411 cells | Proliferation assay | 72 h | Inhibition of Flt3 in human MV411 cells assessed as assessed as proliferation after 72 hrs incubation by spectrophotometry, EC50=0.327 μM | 24779514 |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.43mL 0.49mL 0.24mL |
12.15mL 2.43mL 1.22mL |
24.30mL 4.86mL 2.43mL |
参考文献 |
---|